Senseonics(SENS) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results GERMANTOWN, Md., November 7, 2024 -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights & Accomplishments: · Eversense365 approved in the US as an integrated con ...